Testosterone Injection Information & Coordination for Licensed U.S. Clinics
Testosterone is a prescription hormone available in several FDA-approved dosage forms, including injectable products.
Phoenix Meds Inc. supports licensed healthcare organizations with administrative coordination, documentation, and credential review. We are not a pharmacy, medical practice, manufacturer, prescriber, or dispensing entity, and we do not take possession of medication.
FDA-Approved Testosterone Injection Products
FDA has approved specific prescription drug products containing testosterone.
Current U.S. labeling includes Testosterone Cypionate Injection, USP at 200 mg/mL. Depending on the product, this may be supplied in single-dose or multiple-dose vial presentations. Manufacturer, NDC, package configuration, inactive ingredients, and labeling may differ.
“Testosterone 200 mg” by itself does not identify one specific drug product.
For example, current testosterone cypionate labeling includes 1 mL single-dose vials and 10 mL multiple-dose vials at the same 200 mg/mL concentration. The testosterone cypionate products reviewed for this page are labeled for intramuscular use.
Clinics should confirm the product name, concentration, manufacturer or distributor, NDC, vial presentation, route of administration, and current prescribing information before relying on product-specific information.
Clinical Information
FDA-approved testosterone products are used for specific medical conditions associated with low or absent testosterone.
FDA currently states that approved testosterone products are indicated for men with low or absent testosterone associated with certain medical conditions, including disorders involving the testes, hypothalamus, or pituitary gland.. The approved indication depends on the product involved.
This page does not present testosterone as a general wellness, anti-aging, body-composition, bodybuilding, or performance product.
Phoenix Meds Inc. does not provide treatment protocols, dosing recommendations, or patient-specific medical guidance. Clinicians should use the current prescribing information for the product they are evaluating.
Safety and Prescribing Information
Testosterone products carry product-specific warnings, precautions, contraindications, monitoring requirements, and adverse-reaction information.
FDA has updated testosterone labeling in recent years. In 2025, FDA required class-wide changes involving cardiovascular and blood-pressure information. In June 2026, FDA requested additional updates involving age-related hypogonadism language and safety information concerning prostate cancer and benign prostatic hyperplasia. Clinicians should refer to the current labeling for the product involved.
Healthcare professionals should therefore review the current labeling for the exact testosterone product involved rather than relying on generalized TRT information.
Testosterone Is a Schedule III Controlled Substance
Testosterone is classified as a Schedule III controlled substance under federal law. DEA specifically lists testosterone and anabolic steroids within Schedule III.
That status creates requirements beyond ordinary prescription-drug considerations. The licensed parties involved remain responsible for the prescribing, dispensing, storage, recordkeeping, distribution, and other controlled-substance obligations that apply to their activities.
Phoenix Meds Inc. does not determine whether a prescription or transaction satisfies federal or state controlled-substance requirements.
How Phoenix Meds Supports Licensed Clinics
Our role is administrative.
Depending on the engagement, we may review publicly available licensing or registration information, organize supporting documentation, assist with clinic credential verification, and facilitate administrative communication between professional healthcare entities.
The goal is to reduce administrative back-and-forth around credentialing and documentation while keeping the responsibilities of each party clear.
Our review is not a certification, legal opinion, product approval, or substitute for the clinic’s own due diligence.
Because licenses, registrations, controlled-substance authority, and regulatory records can change, clinics should verify current information before relying on it.
Product Documentation, Shipping and Handling
Product identity, storage, shipping, and handling requirements should be based on the labeling and documentation for the product involved.
For example, current testosterone cypionate 200 mg/mL labeling we reviewed specifies controlled room-temperature storage at 20°C to 25°C (68°F to 77°F) and protection from light. Product requirements may differ, so clinics should always check the applicable label.
We do not manufacture, test, dispense, ship, or take custody of testosterone and do not certify a product’s purity, potency, sterility, authenticity, safety, or clinical suitability.
Clinics should review relevant documentation from the manufacturer, distributor, dispensing entity, or other licensed party responsible for the medication.
Product availability can change. Phoenix Meds Inc. does not promise inventory, delivery dates, or uninterrupted supply.
Administrative Coordination for Licensed Clinics
Licensed U.S. healthcare organizations may contact Phoenix Meds Inc. about our administrative process, credential review, and documentation practices. An administrative inquiry is not a medication order and does not confirm product availability, pricing, clinical suitability, or approval of a proposed transaction.
Clinic Verification
Licensed healthcare organizations may provide relevant professional and facility credentials for administrative verification.
Coordination Review
Verified clinics may request an administrative review so our team can understand the documentation and coordination support involved.
Licensed Parties
Prescribing, dispensing, controlled-substance handling, distribution, shipping, storage, and other regulated medication activities remain with the licensed parties responsible for performing them. Phoenix Meds Inc. does not dispense, ship, or take custody of medications.
Frequently Asked Questions
Is Phoenix Meds Inc. a testosterone supplier?
No. We provide administrative coordination and documentation support for licensed healthcare organizations. Medication sales, dispensing, manufacturing, and shipping are outside our role.
Are testosterone products FDA approved?
FDA has approved specific prescription drug products containing testosterone.
FDA approval applies to the individual product. A preparation described simply as “testosterone” should not automatically be assumed to share the approval status, concentration, route, labeling, or manufacturer of another testosterone product.
Is Testosterone Cypionate Injection available as 200 mg/mL?
Yes. Current U.S. labeling for FDA-approved Testosterone Cypionate Injection, USP products includes 200 mg/mL presentations. Product manufacturer, NDC, vial size, packaging, and labeling may vary. Product manufacturer, NDC, vial size, packaging, and labeling may vary.
Is testosterone a controlled substance?
Yes. DEA classifies testosterone as a Schedule III controlled substance.
The licensed parties involved are responsible for meeting the federal and state controlled-substance requirements applicable to their activities.
Does Phoenix provide testosterone dosing information?
No. Dosing and treatment decisions belong with the treating healthcare professional.
Clinicians should use the current prescribing information for the testosterone product they are evaluating.
Does Phoenix guarantee medication quality?
No. Product-quality claims should be supported by documentation from the manufacturer or licensed entity responsible for the medication.
We do not manufacture, test, or take custody of testosterone.
Does Phoenix confirm that a testosterone transaction is legally compliant?
Our administrative review is not a legal determination.
Clinics and the other licensed parties remain responsible for the federal, state, controlled-substance, prescribing, dispensing, distribution, recordkeeping, and professional requirements that apply to their activities.
Important Notice
Phoenix Meds Inc. provides healthcare sourcing coordination and administrative support for licensed healthcare entities. We are not a pharmacy, medical practice, drug manufacturer, outsourcing facility, prescriber, dispensing entity, or controlled-substance distributor.
This page is intended for professional informational purposes. It is not medical or legal advice and does not replace current FDA-approved labeling, professional clinical judgment, DEA requirements, state law, or advice from qualified regulatory or legal counsel.
Regulatory References
- U.S. Food and Drug Administration – Testosterone Information
- U.S. Food and Drug Administration – FDA Issues Class-Wide Labeling Changes for Testosterone Products
- National Library of Medicine / DailyMed – Testosterone Cypionate Injection, USP, 200 mg/mL
- U.S. Drug Enforcement Administration – Controlled Substance Schedules
- U.S. Drug Enforcement Administration – Anabolic Steroids — DEA Drug & Chemical Evaluation Section